Bacteria in our guts play a significant role in how we digest what we eat, and what we eat includes oral medications we take. But the gut microbiome's impact on drugs may be different from its impact on food because drugs ...
Nov 8, 2022
0
9
University of Queensland research has revealed that having more babies reduces a woman's risk of endometrial cancer.
Nov 7, 2022
0
9
MicroRNA (miRNA) can be used as a biomarker to predict which patients are likely to face breast cancer recurrence and mortality, according to study results published online ahead of print in the Journal of the American College ...
Nov 4, 2022
0
21
A national platform for diagnostic laboratories to share genetic evidence and build consistent interpretations of that information is paving the way for more accurate diagnosis of patient conditions.
Nov 4, 2022
0
3
Researchers at VCU Massey Cancer Center have published new study findings that establish rationale for the use of a class of drugs known as MDA-9 inhibitors as a potential treatment option for aggressive liver cancer. The ...
Nov 3, 2022
0
16
When neurons involved in movement—called motor neurons—form, they must build connections that reach from the brain, brainstem, or spinal cord all the way to the head, arms, or the tips of the toes. How neurons navigate ...
Nov 3, 2022
0
45
Very few people, other than professionals and those close to the young people who have this rare form of cancer have ever heard of a malignant peripheral nerve sheath tumor (MPNST).
Nov 2, 2022
0
27
Approximately one-fourth of the general population worldwide has nonalcoholic fatty liver disease, known as NAFLD, an umbrella term for a range of liver conditions affecting people who drink little to no alcohol. NAFLD can ...
Nov 1, 2022
0
44
For close to two decades Professor Kelly Metcalfe, a senior scientist at Women's College Research Institute and associate dean of research at the University of Toronto's Lawrence S. Bloomberg Faculty of Nursing, has explored ...
Nov 1, 2022
0
2
Patients with cancers that are driven by certain mutations occurring in response to DNA damage can be safely treated with two drugs, olaparib and adavosertib, if they are given in sequence rather than concurrently.
Oct 27, 2022
0
4
